MADISON, N.J., May 3, 2011 /PRNewswire/ — Quest Diagnostics
Incorporated (NYSE:
DGX), the world’s leading provider of diagnostic testing,
information and services, announced today that Spark Acquisition
Corporation, its wholly owned subsidiary (“Spark”), has extended
the expiration of its tender offer to acquire all outstanding
shares of common stock of Celera Corporation (NASDAQ:
CRA) for $8.00 per share in cash, to 5:00 p.m., New York City
time, today, May 3, 2011, unless further extended in accordance
with the Merger Agreement (as defined below) and the applicable
rules and regulations of the Securities and Exchange Commission.
Computershare Trust Company, N.A., the depositary for the tender
offer, has indicated that, as of 5:00 p.m., New York City time, on
May 2, 2011, 82,181,869 shares of common stock of Celera were
issued and outstanding, and 40,451,233 shares of common stock of
Celera have been tendered into and not properly withdrawn from the
tender offer. These shares represent approximately 49.22% of
Celera’s outstanding shares of common stock and 46.10% of Celera’s
outstanding shares of common stock on a fully diluted basis (as
determined pursuant to the Merger Agreement, as defined below).
In addition, the depositary has received commitments to
tender approximately 5,588,479 shares of common stock of Celera in
accordance with the guaranteed delivery procedures, which, when
combined with the shares tendered and not properly withdrawn from
the tender offer, represent approximately 56.02% of Celera’s
outstanding shares of common stock and 52.47% of Celera’s
outstanding shares of common stock on a fully diluted basis (as
determined pursuant to the Merger Agreement).
The tender offer was previously scheduled to expire at 5:00
p.m., New York City time, on May 2, 20
‘/>”/>
